Print

TheraBiogen, Inc. (TRAB.OB) and ECAP Capital Launch Direct Response Marketing Program for Thera Max® Cold and Flu  
2/13/2012 7:35:17 AM

NEW YORK, Feb. 13, 2012 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, announced today that the Company's Direct Response Television (DRTV) commercials will begin airing on national television on Monday, February 13, 2012.

The direct response marketing initiative will begin airing a 2 minute infomercial on cable television channels, including Biography, Lifetime, Family Net, Hallmark, TV Guide, Gameshow, TV Land, the Gospel Music Channel and Planet Green. Thera Max® Cold & Flu Relief will be offered for sale through dedicated toll free phone lines and online at http://www.buytheramax.com.

Kelly Hickel, CEO of TheraBiogen, commented, "We believe that this campaign will produce significant revenues for TheraBiogen and drive consumer awareness of our products." He continued, "I am very enthusiastic about our continued partnership with ECAP Capital on this project. They have a proven history of producing substantial revenues for other products they represent and we plan to continue to promote our products directly to customers through these types of channels."

Charles Brofman, Co-CEO of ECAP Capital added, "At ECAP we strive to support companies with innovative products that fill a consumer need. We believe that TheraBiogen's line of all natural products is effective and safe and we are looking forward to getting these products in the hands of millions of seasonal cold and flu sufferers."

Thera Max® Cold and Flu is an all-natural, non-zinc, non-addictive, over-the-counter cold and flu relief agent. Over 50 million Americans contract the flu each year and consumer demand for a homeopathic, non-zinc remedy is a 2.5 billion dollar market according to research studies.

Thera Max® is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets as well as two of the three largest drug retailers. For more information on Thera Max® visit our website at www.theramaxrelief.com, our Facebook page at http://www.facebook.com/#!/TheraMaxNasalSpray or follow us on Twitter at http://twitter.com/theramaxrelief

About TheraBiogen, Inc.

TheraBiogen is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.

Company Contact:

Public Relations Contact:

Investor Contact:

TheraBiogen, Inc.

Megan Megale

Boutcher & Boutcher

Kelly T. Hickel, CEO

Megale Public Relations

Aimee Boutcher

732-294-8705

703-625-8093

973-239-2878

kthickel@therabiogen.com

mmegale@megalepr.com

Aboutcher@therabiogen.com

SOURCE TheraBiogen, Inc.


//-->